Cargando…
How managed a market? Modes of commissioning in England and Germany
BACKGROUND: In quasi-markets governance over healthcare providers is mediated by commissioners. Different commissioners apply different combinations of six methods of control ('media of power') for exercising governance: managerial performance, negotiation, discursive control, incentives,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663658/ https://www.ncbi.nlm.nih.gov/pubmed/23734631 http://dx.doi.org/10.1186/1472-6963-13-S1-S8 |
_version_ | 1782271012810784768 |
---|---|
author | Sheaff, Rod Chambers, Naomi Charles, Nigel Exworthy, Mark Mahon, Ann Byng, Richard Mannion, Russell |
author_facet | Sheaff, Rod Chambers, Naomi Charles, Nigel Exworthy, Mark Mahon, Ann Byng, Richard Mannion, Russell |
author_sort | Sheaff, Rod |
collection | PubMed |
description | BACKGROUND: In quasi-markets governance over healthcare providers is mediated by commissioners. Different commissioners apply different combinations of six methods of control ('media of power') for exercising governance: managerial performance, negotiation, discursive control, incentives, competition and juridical control. This paper compares how English and German healthcare commissioners do so. METHODS: Systematic comparison of observational national-level case studies in terms of six media of power, using data from multiple sources. RESULTS: The comparison exposes and contrasts two basic generic modes of commissioning: 1. Surrogate planning (English NHS), in which a negotiated order involving micro-commissioning, provider competition, financial incentives and penalties are the dominant media of commissioner power over providers. 2. Case-mix commissioning (Germany), in which managerial performance, an 'episode based' negotiated order and juridical controls appear the dominant media of commissioner power. CONCLUSIONS: Governments do not necessarily maximise commissioners' power over providers by implementing as many media of power as possible because these media interact, some complementing and others inhibiting each other. In particular, patient choice of provider inhibits commissioners' use of provider competition as a means of control. |
format | Online Article Text |
id | pubmed-3663658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36636582013-05-31 How managed a market? Modes of commissioning in England and Germany Sheaff, Rod Chambers, Naomi Charles, Nigel Exworthy, Mark Mahon, Ann Byng, Richard Mannion, Russell BMC Health Serv Res Research BACKGROUND: In quasi-markets governance over healthcare providers is mediated by commissioners. Different commissioners apply different combinations of six methods of control ('media of power') for exercising governance: managerial performance, negotiation, discursive control, incentives, competition and juridical control. This paper compares how English and German healthcare commissioners do so. METHODS: Systematic comparison of observational national-level case studies in terms of six media of power, using data from multiple sources. RESULTS: The comparison exposes and contrasts two basic generic modes of commissioning: 1. Surrogate planning (English NHS), in which a negotiated order involving micro-commissioning, provider competition, financial incentives and penalties are the dominant media of commissioner power over providers. 2. Case-mix commissioning (Germany), in which managerial performance, an 'episode based' negotiated order and juridical controls appear the dominant media of commissioner power. CONCLUSIONS: Governments do not necessarily maximise commissioners' power over providers by implementing as many media of power as possible because these media interact, some complementing and others inhibiting each other. In particular, patient choice of provider inhibits commissioners' use of provider competition as a means of control. BioMed Central 2013-05-24 /pmc/articles/PMC3663658/ /pubmed/23734631 http://dx.doi.org/10.1186/1472-6963-13-S1-S8 Text en Copyright © 2013 Sheaff et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Sheaff, Rod Chambers, Naomi Charles, Nigel Exworthy, Mark Mahon, Ann Byng, Richard Mannion, Russell How managed a market? Modes of commissioning in England and Germany |
title | How managed a market? Modes of commissioning in England and Germany |
title_full | How managed a market? Modes of commissioning in England and Germany |
title_fullStr | How managed a market? Modes of commissioning in England and Germany |
title_full_unstemmed | How managed a market? Modes of commissioning in England and Germany |
title_short | How managed a market? Modes of commissioning in England and Germany |
title_sort | how managed a market? modes of commissioning in england and germany |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663658/ https://www.ncbi.nlm.nih.gov/pubmed/23734631 http://dx.doi.org/10.1186/1472-6963-13-S1-S8 |
work_keys_str_mv | AT sheaffrod howmanagedamarketmodesofcommissioninginenglandandgermany AT chambersnaomi howmanagedamarketmodesofcommissioninginenglandandgermany AT charlesnigel howmanagedamarketmodesofcommissioninginenglandandgermany AT exworthymark howmanagedamarketmodesofcommissioninginenglandandgermany AT mahonann howmanagedamarketmodesofcommissioninginenglandandgermany AT byngrichard howmanagedamarketmodesofcommissioninginenglandandgermany AT mannionrussell howmanagedamarketmodesofcommissioninginenglandandgermany |